Skip to main content
Log in

Long term differential consequences of miglustat therapy on intestinal disaccharidases

  • Original Article
  • Published:
Journal of Inherited Metabolic Disease

Abstract

Miglustat is an oral medication for treatment of lysosomal storage diseases such as Gaucher disease type I and Niemann Pick disease type C. In many cases application of Miglustat is associated with symptoms similar to those observed in intestinal carbohydrate malabsorption. Previously, we have demonstrated that intestinal disaccharidases are inhibited immediately by Miglustat in the intestinal lumen. Nevertheless, the multiple functions of Miglustat hypothesize long term effects of Miglustat on intracellular mechanisms, including glycosylation, maturation and trafficking of the intestinal disaccharidases. Our data show that a major long term effect of Miglustat is its interference with N-glycosylation of the proteins in the ER leading to a delay in the trafficking of sucrase-isomaltase. Also association with lipid rafts and plausibly apical targeting of this protein is partly affected in the presence of Miglustat. More drastic is the effect of Miglustat on lactase-phlorizin hydrolase which is partially blocked intracellularly. The de novo synthesized SI and LPH in the presence of Miglustat show reduced functional efficiencies according to altered posttranslational processing of these proteins. However, at physiological concentrations of Miglustat (≤50 μM) a major part of the activity of these disaccharidases is found to be still preserved, which puts the charge of the observed carbohydrate maldigestion mostly on the direct inhibition of disaccharidases in the intestinal lumen by Miglustat as the immediate side effect.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

SI:

sucrase-isomaltase

MGA:

maltase-glucoamylase

LPH:

lactase-phlorizin hydrolase

BBM:

brush border membrane

DRM:

detergent-resistant membranes

References

  • Alfalah M, Jacob R, Preuss U, Zimmer KP, Naim H, Naim HY (1999) O-linked glycans mediate apical sorting of human intestinal sucrase-isomaltase through association with lipid rafts. Curr Biol 9(11):593–596

    Article  PubMed  CAS  Google Scholar 

  • Alfalah M, Keiser M, Leeb T, Zimmer KP, Naim HY (2009) Compound heterozygous mutations affect protein folding and function in patients with congenital sucrase-isomaltase deficiency. Gastroenterology 136(3):883–892

    Article  PubMed  CAS  Google Scholar 

  • Alonzi DS, Neville DCA, Lachmann RH, Dwek RA, Butters TD (2008) Glucosylated free oligosaccharides are biomarkers of endoplasmic- reticulum α-glucosidase inhibition. Biochem J 409(2):571–580

    Article  PubMed  CAS  Google Scholar 

  • Amiri M, Naim HY (2012) Miglustat-induced intestinal carbohydrate malabsorption is due to the inhibition of alpha-glucosidases, but not beta-galactosidases. J Inherit Metab Dis 35(6):949–954

    Article  PubMed  CAS  Google Scholar 

  • Beaulieu JF, Nichols B, Quaroni A (1989) Posttranslational regulation of sucrase-isomaltase expression in intestinal crypt and villus cells. J Biol Chem 264(33):20000–20011

    PubMed  CAS  Google Scholar 

  • Behrendt M, Keiser M, Hoch M, Naim HY (2009) Impaired trafficking and subcellular localization of a mutant lactase associated with congenital lactase deficiency. Gastroenterology 136(7):2295–2303

    Article  PubMed  CAS  Google Scholar 

  • Belmatoug N, Burlina A, Giraldo P et al (2011) Gastrointestinal disturbances and their management in miglustat-treated patients. J Inherit Metab Dis 34(5):991–1001

    Article  PubMed  CAS  Google Scholar 

  • Bergeron JJM, Brenner MB, Thomas DY, Williams DB (1994) Calnexin - a membrane-bound chaperone of the endoplasmic-reticulum. Trends Biochem Sci 19(3):124–128

    Article  PubMed  CAS  Google Scholar 

  • Butters TD, Dwek RA, Platt FM (2005) Imino sugar inhibitors for treating the lysosomal glycosphingolipidoses. Glycobiology 15(10):R43–R52

    Article  Google Scholar 

  • Chamberlain LH (2004) Detergents as tools for the purification and classification of lipid rafts. FEBS Lett 559(1–3):1–5

    Article  PubMed  CAS  Google Scholar 

  • Cox T, Lachmann R, Hollak C et al (2000) Novel oral treatment of Gaucher’s disease with N-butyldeoxynojirimycin (OGT 918) to decrease substrate biosynthesis. Lancet 355(9214):1481–1485

    Article  PubMed  CAS  Google Scholar 

  • Cox TM, Aerts J, Andria G (2003) The role of the iminosugar N-butyldeoxynojirimycin (miglustat) in the management of type I (non-neuronopathic) Gaucher disease: a position statement. J Inherit Metab Dis 26(6):513–526

    Article  PubMed  CAS  Google Scholar 

  • Fuhrmann U, Bause E, Ploegh H (1985) Inhibitors of oligosaccharide processing. BBA-Gene Struct Expr 825(2):95–110

    Article  CAS  Google Scholar 

  • Hanzal-Bayer MF, Hancock JF (2007) Lipid rafts and membrane traffic. FEBS Lett 581(11):2098–2104

    Article  PubMed  CAS  Google Scholar 

  • Hauri HP, Roth J, Sterchi EE, Lentze MJ (1985) Transport to cell-surface of intestinal sucrase-isomaltase is blocked in the Golgi-apparatus in a patient with congenital sucrase-isomaltase deficiency. Proc Natl Acad Sci U S A 82(13):4423–4427

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Hauri HP, Sander B, Naim H (1994) Induction of lactase biosynthesis in the human intestinal epithelial-cell line Caco-2. Eur J Biochem 219(1–2):539–546

    Article  PubMed  CAS  Google Scholar 

  • Helenius A, Aebi M (2004) roles of N-linked glycans in the endoplasmic reticulum. Annu Rev Biochem 73(1):1019–1049

    Article  PubMed  CAS  Google Scholar 

  • Ingram CJE, Mulcare CA, Itan Y, Thomas MG, Swallow DM (2009) Lactose digestion and the evolutionary genetics of lactase persistence. Hum Genet 124(6):579–591

    Article  PubMed  CAS  Google Scholar 

  • Jacob R, Alfalah M, Grunberg J, Obendorf M, Naim HY (2000) Structural determinants required for apical sorting of an intestinal brush-border membrane protein. J Biol Chem 275(9):6566–6572

    Article  PubMed  CAS  Google Scholar 

  • Jacob R, Heine M, Alfalah M, Naim HY (2003) Distinct cytoskeletal tracks direct individual vesicle populations to the apical membrane of epithelial cells. Curr Biol 13(7):607–612

    Article  PubMed  CAS  Google Scholar 

  • Jacob R, Naim HY (2001) Apical membrane proteins are transported in distinct vesicular carriers. Curr Biol 11(18):1444–1450

    Article  PubMed  CAS  Google Scholar 

  • Järvelä I, Sabri Enattah N, Kokkonen J, Varilo T, Savilahti E, Peltonen L (1998) Assignment of the locus for congenital lactase deficiency to 2q21, in the vicinity of but separate from the lactase-phlorizin hydrolase gene. Am J Hum Gen 63(4):1078–1085

    Article  Google Scholar 

  • Keiser M, Alfalah M, Propsting MJ, Castelletti D, Naim HY (2006) Altered folding, turnover, and polarized sorting act in concert to define a novel pathomechanism of congenital sucrase-isomaltase deficiency. J Biol Chem 281(20):14393–14399

    Article  PubMed  CAS  Google Scholar 

  • Kuokkanen M, Enattah NS, Oksanen A, Savilahti E, Orpana A, Jarvela I (2003) Transcriptional regulation of the lactase-phlorizin hydrolase gene by polymorphisms associated with adult-type hypolactasia. Gut 52(5):647–652

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  • Lindner R, Naim HY (2009) Domains in biological membranes. Exp Cell Res 315(17):2871–2878

    Article  PubMed  CAS  Google Scholar 

  • Maattanen P, Gehring K, Bergeron JJM, Thomas DY (2010) Protein quality control in the ER: the recognition of misfolded proteins. Sem Cell Dev Biol 21(5):500–511

    Article  Google Scholar 

  • Maiuri L, Raia V, Potter J et al (1991) mosaic pattern of lactase expression by villous enterocytes in human adult-type hypolactasia. Gastroenterology 100(2):359–369

    PubMed  CAS  Google Scholar 

  • Naim HY, Lentze MJ (1992) impact of O-glycosylation on the function of human intestinal lactase-phlorizin hydrolase - characterization of glycoforms varying in enzyme-activity and localization of O-glycoside addition. J Biol Chem 267(35):25494–25504

    PubMed  CAS  Google Scholar 

  • Naim HY, Sterchi EE, Lentze MJ (1987) biosynthesis and maturation of lactase phlorizin hydrolase in the human small intestinal epithelial-cells. Biochem J 241(2):427–434

    PubMed  CAS  PubMed Central  Google Scholar 

  • Naim HY, Sterchi EE, Lentze MJ (1988a) Biosynthesis of the human sucrase-isomaltase complex - differential O-glycosylation of the sucrase subunit correlates with its position within the enzyme complex. J Biol Chem 263(15):7242–7253

    PubMed  CAS  Google Scholar 

  • Naim HY, Sterchi EE, Lentze MJ (1988b) Structure, biosynthesis, and glycosylation of human small intestinal maltase-glucoamylase. J Biol Chem 263(36):19709–19717

    PubMed  CAS  Google Scholar 

  • Platt FM, Neises GR, Dwek RA, Butters TD (1994) N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J Biol Chem 269(11):8362–8365

    PubMed  CAS  Google Scholar 

  • Rousset M, Laburthe M, Pinto M et al (1985) Enterocytic differentiation and glucose-utilization in the human-colon tumor-cell line Caco-2 - modulation by forskolin. J Cell Physiol 123(3):377–385

    Article  PubMed  CAS  Google Scholar 

  • Sander P, Alfalah M, Keiser M et al (2006) Novel mutations in the human sucrase-isomaltase gene (SI) that cause congenital carbohydrate malabsorption. Hum Mutat 27(1):119

    Article  PubMed  Google Scholar 

  • Saunier B, Kilker RD, Tkacz JS, Quaroni A, Herscovics A (1982) inhibition of N-linked complex oligosaccharide formation by 1-deoxynojirimycin, an inhibitor of processing glucosidases. J Biol Chem 257(23):4155–4161

    Google Scholar 

  • Uhrich S, Wu Z, Huang J-Y, Scott CR (2012) Four mutations in the SI gene are responsible for the majority of clinical symptoms of CSID. J Pediatr Gastroenterol Nutr 55:S34–S35. doi:10.1097/1001.mpg.0000421408.0000465257.b0000421405

    Article  PubMed  Google Scholar 

  • Venier RE, Igdoura SA (2012) Miglustat as a therapeutic agent: prospects and caveats. J Med Genet 49(9):591–597

    Article  PubMed  CAS  Google Scholar 

  • Wetzel G, Heine M, Rohwedder A, Naim HY (2009) Impact of glycosylation and detergent-resistant membranes on the function of intestinal sucrase-isomaltase. Biol Chem 390(7):545–549

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

During the course of this work M.A. was a recipient of a Ph. D. scholarship from the German Academic Exchange Service (DAAD), Bonn, Germany. We would like to thank Actelion Pharmaceuticals GmbH, Freiburg, Germany for providing Miglustat for this study.

Compliance with Ethics Guideline

Conflict of interest

None.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Hassan Y. Naim.

Additional information

Communicated by: Matthias Baumgartner

Electronic supplementary material

Below is the link to the electronic supplementary material.

ESM 1

(PDF 137 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Amiri, M., Naim, H.Y. Long term differential consequences of miglustat therapy on intestinal disaccharidases. J Inherit Metab Dis 37, 929–937 (2014). https://doi.org/10.1007/s10545-014-9725-4

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10545-014-9725-4

Keywords

Navigation